Chevy Chase Trust Holdings, Inc. Gsk PLC Transaction History

Chevy Chase Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $45,425 - $68,313	-1,399 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $58,758 - $67,501	1,399 New	1,399 $67,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $261,727 - $295,585	-6,924 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$39.75 - $42.69 $47,501 - $51,014	1,195 Added 20.86%	6,924 $278,000
Q1 2018 Apr 10, 2018	BUY	$36.18 - $40.15 $207,275 - $230,019	5,729 New	5,729 $224,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.